NCT04541108 2024-04-18Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer TherapiesPresage BiosciencesPhase EARLY_PHASE1 Recruiting15 enrolled
NCT03454451 2023-12-21CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced CancersCorvus Pharmaceuticals, Inc.Phase 1 Completed117 enrolled